title: Response to Kunte et al.
authors: From the Department of Psychiatry, Dalhousie University, Halifax, N.S., Canada.
authors: Rudolf
authors: R
authors: Uher
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000378:metabolism*; D015283:Citalopram / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007249:Inflammation / Q000097:blood*; D008297:Male; D009661:Nortriptyline / Q000627:therapeutic use*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D015283:Citalopram; D002097:C-Reactive Protein; D009661:Nortriptyline